Orchestra BioMed Holdings (OBIO) Assets (2020 - 2026)

Orchestra BioMed Holdings (OBIO) has 7 years of Assets data on file, last reported at $100.7 million in Q1 2026.

• On a quarterly basis, Assets rose 70.46% year-over-year to $100.7 million in Q1 2026; TTM through Mar 2026 was $100.7 million, a 70.46% increase from a year earlier, with the FY2025 full-year figure at $114.9 million, up 50.78% from the prior year.
• Assets for Q1 2026 stood at $100.7 million, down from $114.9 million in the prior quarter.
• Over the last five years, Assets for OBIO reached as high as $161.6 million in Q2 2022 and fell as low as $42.8 million in Q2 2025.
• Historically, Assets has averaged $99.4 million across 5 years, with a median of $95.6 million in 2022.
• Across the five-year window, Assets plunged 57.59% in 2022 and jumped 70.46% in 2026, its largest moves.
• Year by year, Assets stood at $95.6 million in 2022, then retreated by 0.38% to $95.2 million in 2023, then fell by 20.0% to $76.2 million in 2024, then soared by 50.78% to $114.9 million in 2025, then dropped by 12.36% to $100.7 million in 2026.
• Per Business Quant data, the three most recent Assets figures were $100.7 million in Q1 2026, $114.9 million in Q4 2025, and $104.8 million in Q3 2025.